Cargando…

2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT

An important feature of gene-directed enzyme-prodrug therapy is that prodrug activation can provide diffusible cytotoxic metabolites capable of generating a local bystander effect in tumours. Activation of the aziridinyl dinitrobenzamide CB 1954 by E. coli nitroreductase (NTR) provides a bystander e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helsby, N A, Ferry, D M, Patterson, A V, Pullen, S M, Wilson, W R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409616/ https://www.ncbi.nlm.nih.gov/pubmed/14997211 http://dx.doi.org/10.1038/sj.bjc.6601612

Ejemplares similares

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
por: Vass, S O, et al.
Publicado: (2009)

Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil
por: Palmer, D H, et al.
Publicado: (2003)

Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro
por: Teng, Geling, et al.
Publicado: (2016)

An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells
por: Yashiro, M, et al.
Publicado: (2011)

Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954
por: Talib, Wamidh H., et al.
Publicado: (2013)

Proceedings: Protection against the cytotoxic aziridine CB1954 by an arylimidazole with anti-inflammatory activity.
por: Hickman, J. A., et al.
Publicado: (1975)

Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo
por: Ewald, J A, et al.
Publicado: (2008)

Gap junction communication dynamics and bystander effects from ultrasoft X-rays
por: Edwards, G O, et al.
Publicado: (2004)

Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
por: Hall, Belinda S., et al.
Publicado: (2011)

Single Amino Acid Switch between a Flavin-Dependent Dehalogenase and Nitroreductase
por: Mukherjee, Arnab, et al.
Publicado: (2015)

Evolutionary aspects of the Viridiplantae nitroreductases
por: Dabravolski, Siarhei A.
Publicado: (2020)

The Role of Nitroreductases in Resistance to Nitroimidazoles
por: Thomas, Carol, et al.
Publicado: (2021)

Nitroreductase Activites in Giardia lamblia: ORF 17150 Encodes a Quinone Reductase with Nitroreductase Activity
por: Müller, Joachim, et al.
Publicado: (2021)

A proliferation-dependent bystander effect in primary porcine and human urothelial explants in response to targeted irradiation
por: Belyakov, O V, et al.
Publicado: (2003)

Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer
por: Hlavaty, Juraj, et al.
Publicado: (2012)

Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity
por: Jones, D J L, et al.
Publicado: (2004)

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB(2)
por: Olea-Herrero, N, et al.
Publicado: (2009)

CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype
por: Helsby, N A, et al.
Publicado: (2008)

Informing Efforts to Develop Nitroreductase for Amine Production
por: Miller, Anne-Frances, et al.
Publicado: (2018)

Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid
por: Niedre, M J, et al.
Publicado: (2005)

Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
por: Wyllie, Susan, et al.
Publicado: (2016)

Nitroreductase-Activatable Morpholino Oligonucleotides for in Vivo Gene Silencing
por: Yamazoe, Sayumi, et al.
Publicado: (2014)

Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging
por: Vorobyeva, Anzhelika G., et al.
Publicado: (2015)

Identification of Enterococcus faecalis enzymes with azoreductases and/or nitroreductase activity
por: Chalansonnet, Valérie, et al.
Publicado: (2017)

1954 Medical Progress
por: Busch, Harris
Publicado: (1954)

CERN 1954-1964
Publicado: (1964)

CERN was established in 1954
Publicado: (2009)

In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles
por: Bradshaw, T D, et al.
Publicado: (2002)

Structure and Dynamics of Three Escherichia coli NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954
por: Day, Martin A., et al.
Publicado: (2023)

A mammalianized synthetic nitroreductase gene for high-level expression
por: Grohmann, Maik, et al.
Publicado: (2009)

Evolutionary and molecular foundations of multiple contemporary functions of the nitroreductase superfamily
por: Akiva, Eyal, et al.
Publicado: (2017)

Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis
por: Negri, Ana, et al.
Publicado: (2018)

Biochemical and structural characterization of Haemophilus influenzae nitroreductase in metabolizing nitroimidazoles
por: Liu, Dake, et al.
Publicado: (2022)

Realizing the Continuous Chemoenzymatic Synthesis of Anilines Using an Immobilized Nitroreductase
por: Cosgrove, Sebastian C., et al.
Publicado: (2023)

Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009)

CERN 40 (1954-1994)
Publicado: (1994)

CERN 40 (1954-1994)
Publicado: (1994)

MODERN TREATMENT YEARBOOK, 1954
Publicado: (1954)

Henry Bunting 1911-1954
por: Mendenhall, Thomas C.
Publicado: (1954)

Building the laboratory, 1954-1959
por: Krige, Gerhard John
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_qv0koog0bo0lcfllh00q5up16f